Why the study?
Are NOS1AP genetic variants associated with prolonged QT interval duration in a type 2 diabetes-enriched population?
Are NOS1AP genetic variants associated with prolonged QT interval duration in a type 2 diabetes-enriched population?
No takes yet. Share an insight, caveat, or question.
NOS1AP variant may prolong QT in diabetic European Americans; leaves open replication and any role for genotyping in arrhythmia risk assessment.
Lehtinen et al. (2008) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: